Immunotherapy and Term Life Insurance (2026)

If you’re receiving immunotherapy or recently finished a course of it, you’re probably wondering whether term life insurance is even possible. The short answer is yes, but the details matter a lot. The type of cancer, your stage at diagnosis, how long you’ve been cancer free, and how your body responded to treatment all play into what carriers will offer you. If your plans shift from term toward permanent coverage with cash value, our IUL company selection guide lays out the caps and fees that shape index growth.

At Insurance By Heroes, we understand what it feels like to face uncertainty. Our agency was founded by a former first responder and military spouse, and our team comes from backgrounds in law enforcement, fire service, EMS, healthcare, and education. Those public service values, showing up for people when things are hard, shape how we work every day. We’re also an independent agency, which means we don’t sell for one insurance company. We shop dozens of carriers on your behalf, and that distinction matters more than most people realize when you have a complex medical history.

Does Immunotherapy Affect Life Insurance?

Yes, but probably not the way you think. Underwriters don’t see “immunotherapy” on your application and automatically stamp it declined. What they actually care about is the underlying condition being treated and how well it’s been managed.

Immunotherapy is used for a wide range of cancers, from melanoma to lung cancer to lymphoma. The treatment itself tells the underwriter something about the severity of your diagnosis, but it’s one piece of a much bigger picture. A person who completed immunotherapy for early stage melanoma three years ago and has been cancer free since is in a completely different position than someone currently receiving immunotherapy for advanced lung cancer.

Here’s the key insight. Underwriters care more about the condition than the medication. Two people on the same immunotherapy drug can get wildly different offers because their cancers, stages, and outcomes are different.

What Underwriters Actually Look At

When you apply for term life insurance with an immunotherapy history, the underwriting team is building a risk profile based on several specific factors.

The cancer type and stage at diagnosis are the starting point. Stage 1 thyroid cancer and Stage 3 lung cancer exist in completely different universes from an insurance perspective. Early stage cancers with good natural prognoses (thyroid, early breast, early prostate, testicular) are far more insurable than aggressive cancers like pancreatic or mesothelioma.

Time cancer free is everything. This is the single biggest factor in your application. Under one year since treatment, most carriers will postpone or offer only guaranteed issue policies. At two to three years cancer free, doors start opening depending on your cancer type and stage. Three to five years is a major turning point, and five plus years puts you in a much stronger position where some cancers approach near standard rates. For applicants still inside that first year, Immunotherapy guaranteed-issue life insurance offers a no-exam route while standard underwriting postpones.

Beyond the timeline, underwriters look at tumor grade, biomarker and receptor status, whether you had surgery alone or a combination of treatments, and your current surveillance compliance. They also want to know about treatment side effects. Certain immunotherapy and chemotherapy agents can cause cardiotoxicity, and if you received those drugs, having a cardiology clearance on file helps enormously.

Your pathology report is your best friend in this process. It contains the stage, grade, and biomarker information that underwriters use to make their decisions. Get it. Understand it. Have it ready before you apply.

Immunotherapy and Life Insurance. Why an Independent Agency Matters

Here’s something most people don’t know about how the insurance industry works. If you go to a single carrier’s website or work with a captive agent (someone who represents only one company), you’re seeing one company’s opinion of your risk. If that company declines you or offers a high table rating, the captive agent has nowhere else to go.

Every insurance carrier has its own underwriting guidelines. The same person, same cancer history, same immunotherapy treatment, can see rates vary by 50% or more between companies for identical coverage. One carrier might be aggressive about offering coverage to breast cancer survivors who are three years out. Another might specialize in favorable ratings for prostate cancer patients with low Gleason scores. A third might have the most competitive rates for melanoma survivors.

An independent agency like Insurance By Heroes works with dozens of carriers and knows which ones look most favorably on specific situations. We’ve seen it firsthand. A client gets declined by one carrier and approved at a Table 4 rating by another. That difference can mean hundreds of dollars a year in premiums. Getting quotes from multiple carriers through an independent agent isn’t just convenient. It’s the single most effective way to find an affordable rate when you have a cancer history.

Why Term Life Insurance Makes Sense During or After Immunotherapy

Term life insurance is often the best fit for someone with a cancer treatment history, and here’s why.

It’s the most affordable type of coverage. If you’re receiving a table rating (which is common after cancer treatment), the premium increase on a term policy is much more manageable than on a permanent policy. A Table 2 rating on a $500,000 twenty year term for a 40 year old might mean paying $65 per month instead of $45 per month. That’s less than most streaming subscriptions combined.

Term lengths of 10, 15, 20, 25, or 30 years let you match your coverage to specific financial obligations. If your kids are young, a 20 year term covers them through college. If you just bought a house, a 30 year term matches the mortgage. For someone with a recent cancer history, a shorter term (10 or 15 years) may be easier to qualify for and lets you lock in a rate now.

And here’s something many people overlook. Many term policies include a conversion option, which means you can convert to a permanent policy later without going through medical underwriting again. So if your health continues to improve and you decide you want lifelong coverage, you have that path available without requalifying.

Tips for the Best Outcome on Your Application

Timing your application matters. If you just finished immunotherapy last month, most carriers will postpone. Waiting until you’re at least two years cancer free (and ideally three to five years) dramatically improves your options. Every month of clean surveillance adds to your case.

Gather your medical records before you apply. You’ll need your pathology report, treatment summary, most recent oncology visit notes, recent imaging reports, and tumor marker results if applicable. Anecdotal recollections of your diagnosis won’t hold up in underwriting. Specific documentation will.

Stay compliant with your surveillance plan. Gaps in follow up care are a red flag for underwriters. Consistent oncology visits and clean scans tell a story of stability and responsible management.

Don’t assume you’ll be declined. This is one of the biggest myths out there. Getting declined by one carrier means nothing about your chances with the other 30 plus carriers an independent agent can check. Different companies have vastly different guidelines for cancer survivors.

And don’t wait for “perfect” health to apply. Every birthday increases your base premium rate regardless of health. Conditions can develop complications that worsen your rating class. Locking in a rate now, even at a table rating, often beats gambling on better health later. This isn’t a scare tactic. It’s math.

Common Myths About Immunotherapy and Insurance

“Immunotherapy means I’m uninsurable.” Not true. Immunotherapy is used for many treatable cancers with good outcomes. Early stage melanoma, certain breast cancers, and kidney cancers treated with immunotherapy can be very insurable after adequate time cancer free.

“I need to be cured before I can apply.” There’s an important distinction between remission and cured. Many carriers will offer coverage to applicants in stable remission with good surveillance, especially after the three to five year mark. You don’t necessarily need a doctor to declare you “cured.”

“My employer’s group coverage is enough.” Group life insurance is typically one to two times your salary with no portability. If you leave that job, you lose the coverage. And you’ll be older and potentially harder to insure when you try to replace it. Having your own individual term policy means your coverage follows you regardless of employment.

“All carriers will charge me the same thing.” This might be the most expensive myth of all. Carriers vary enormously in how they rate cancer histories. The best way to know your actual rate is to get personalized quotes based on your specific situation. When you’re ready to see real numbers, the quote button on this page takes under a minute.

Frequently Asked Questions

Can I get term life insurance while on immunotherapy? It depends on your specific situation. If you’re actively receiving immunotherapy, most carriers will postpone until treatment is complete. Once you’ve finished treatment and have some cancer free time (typically two to three years minimum), traditional term life options begin opening up. Some guaranteed issue products may be available sooner.

Does immunotherapy increase life insurance rates? The immunotherapy itself isn’t what drives rate increases. It’s the underlying cancer, its stage, and your current health status. Someone who had early stage cancer treated with immunotherapy and has been cancer free for five years may receive only a mild table rating. Someone with advanced stage disease will face higher rates or limited options. Every carrier weighs these factors differently, which is why comparing quotes is so valuable.

What documents do I need to apply for term life insurance after immunotherapy? Your pathology report is the most critical document. You’ll also want your treatment summary, most recent oncology notes, recent imaging reports (CT, MRI, or PET scans from the past six months), and tumor marker results if applicable. Having these ready before you apply prevents delays and gives the underwriter a complete picture.

Should I wait until I’ve been cancer free longer before applying? There’s a real tradeoff here. Longer cancer free periods do improve your rating class and open more carrier options. But every year you wait, your age based rates increase too. If you’re past the two to three year mark with good surveillance results, it’s worth getting quotes now to see where you stand. Getting quotes is free and gives you real numbers instead of guesswork. You can always reapply later if you want to try for a better rating class.

Related medications

Immunotherapy is one of many prescriptions underwriters weigh when they read a term application, and these term rate guides answer the same question for PrEP term life insurance rates, Dutasteride term life insurance rates, Trazodone term life insurance and Stimulant term life insurance.